tiprankstipranks
Teva Pharmaceutical Industries Limited (MX:TEVAN)
NYSE:TEVAN
TEVAN
Teva Pharmaceutical
RESEARCH TOOLSreports

Teva Pharmaceutical (TEVAN) Revenue

0 Followers
StatisticsMarket CapRevenue

Teva Pharmaceutical Revenue

Teva Pharmaceutical had a revenue of 4.14B in the quarter ending Jun 30, 2026, with 4.04%. This bring the company's revenue in the last twelve months to 17.31B, Increased -0.20%. In the fiscal year ending Dec 31, 2025, Teva Pharmaceutical had annual revenue of 17.26B with 4.31% growth.
Revenue (ttm)
17.31B
Revenue Growth
-4.71%
P/S Ratio
40.53
Revenue/Employee
$539,146
Employees
32,008
Market Cap
$699.47B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
17.26B713.00M+4.31%
Dec 31, 2024
16.54B699.00M+4.41%
Dec 31, 2023
15.85B920.00M+6.16%
Dec 31, 2022
14.93B-953.00M-6.00%
Dec 31, 2021
15.88B-781.00M-4.69%
Dec 31, 2020
16.66B-228.00M-1.35%
Dec 31, 2019
16.89B-1.97B-10.43%
Dec 31, 2018
18.85B-3.53B-15.77%
Dec 31, 2017
22.39B――